Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 3
2006 3
2007 3
2008 2
2009 4
2010 5
2011 6
2012 10
2013 5
2014 5
2015 14
2016 8
2017 12
2018 11
2019 4
2020 4
2021 3
2022 6
2023 2
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Enzalutamide in metastatic prostate cancer before chemotherapy.
Beer TM, Armstrong AJ, Rathkopf DE, Loriot Y, Sternberg CN, Higano CS, Iversen P, Bhattacharya S, Carles J, Chowdhury S, Davis ID, de Bono JS, Evans CP, Fizazi K, Joshua AM, Kim CS, Kimura G, Mainwaring P, Mansbach H, Miller K, Noonberg SB, Perabo F, Phung D, Saad F, Scher HI, Taplin ME, Venner PM, Tombal B; PREVAIL Investigators. Beer TM, et al. N Engl J Med. 2014 Jul 31;371(5):424-33. doi: 10.1056/NEJMoa1405095. Epub 2014 Jun 1. N Engl J Med. 2014. PMID: 24881730 Free PMC article. Clinical Trial.
[Bone metastases].
Ohlmann CH. Ohlmann CH. Aktuelle Urol. 2013 Mar;44(2):141-9. doi: 10.1055/s-0032-1324997. Epub 2013 Apr 11. Aktuelle Urol. 2013. PMID: 23580385 German.
[Role of local treatments in prostate cancer].
Ohlmann CH, Grimm MO. Ohlmann CH, et al. Urologie. 2024 Mar;63(3):213-214. doi: 10.1007/s00120-024-02286-7. Epub 2024 Mar 6. Urologie. 2024. PMID: 38446156 German. No abstract available.
Erstlinientherapie beim lokal fortgeschrittenen oder metastasierten Urothelkarzinom: Eine randomisierte, kontrollierte Phase-III-Studie zum Vergleich von Pembrolizumab mit und ohne platinbasierter Kombinations-Chemotherapie und der alleinigen Chemotherapie bei Patienten mit fortgeschrittenem oder metastasiertem Urothelkarzinom (Keynote-361) AB 54/16 der AUO.
Rexer H, Ohlmann CH, Retz M. Rexer H, et al. Among authors: ohlmann ch. Aktuelle Urol. 2018 Feb;49(1):21-22. doi: 10.1055/s-0043-125341. Epub 2018 Feb 1. Aktuelle Urol. 2018. PMID: 29390213 German. No abstract available.
Erstlinientherapie beim lokal fortgeschrittenen oder metastasierten Urothelkarzinom: Eine randomisierte, doppelblinde Phase-III-Multicenterstudie zur adjuvanten Nivolumab-Therapie versus Placebo bei Patienten mit invasivem Hochrisiko-Urothelkarzinom (CheckMate 274) – AB 58/17 der AUO.
Rexer H, Ohlmann CH, Gschwend J. Rexer H, et al. Among authors: ohlmann ch. Aktuelle Urol. 2018 Aug;49(4):308-309. doi: 10.1055/a-0633-7395. Epub 2018 Aug 7. Aktuelle Urol. 2018. PMID: 30086585 German. No abstract available.
Is there an anti-androgen withdrawal syndrome for enzalutamide?
von Klot CA, Kramer MW, Böker A, Herrmann TR, Peters I, Kuczyk MA, Ligges U, Gschwend JE, Retz M, Schmid SC, Stenzl A, Schwentner C, Todenhöfer T, Stöckle M, Ohlmann CH, Azone I, Mager R, Bartsch G, Haferkamp A, Heidenreich A, Piper C, Merseburger AS. von Klot CA, et al. Among authors: ohlmann ch. World J Urol. 2014 Oct;32(5):1171-6. doi: 10.1007/s00345-014-1288-3. Epub 2014 Apr 2. World J Urol. 2014. PMID: 24691670
[Nephron-sparing surgery 2012].
Janssen M, Treiyer EA, Saar M, Ohlmann CH, Kamradt J, Junker K, Stöckle M, Siemer S. Janssen M, et al. Among authors: ohlmann ch. Aktuelle Urol. 2012 Dec;43(6):399-402. doi: 10.1055/s-0032-1330002. Epub 2012 Nov 29. Aktuelle Urol. 2012. PMID: 23196778 Review. German.
[Circumcision with frenulum-plasty].
Ohlmann CH. Ohlmann CH. Aktuelle Urol. 2006 Mar;37(2):148-52; quiz 153-4. doi: 10.1055/s-2005-873209. Aktuelle Urol. 2006. PMID: 16625474 German. No abstract available.
Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks.
Pfestroff A, Luster M, Jilg CA, Olbert PJ, Ohlmann CH, Lassmann M, Maecke HR, Ezziddin S, Bodei L; Radionuclide Therapy Committee of the European Association of Nuclear Medicine. Pfestroff A, et al. Among authors: ohlmann ch. Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):1971-5. doi: 10.1007/s00259-015-3186-3. Eur J Nucl Med Mol Imaging. 2015. PMID: 26373947 No abstract available.
[Follow-up of urological tumor treatment].
Ohlmann CH, Albers P, Boehm K, Graefen M, Hakenberg OW, Kuczyk M, Graf J, Peters I, Protzel C. Ohlmann CH, et al. Urologe A. 2015 Sep;54(9):1223-33. doi: 10.1007/s00120-015-3936-7. Urologe A. 2015. PMID: 26246111 Review. German.
102 results